NCT02139241View on ClinicalTrials.gov

The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Coronary Artery Bypass Graft Triple VesselHypotension
Interventions
DRUG

Ramosetron

0.3 mg IV as bolus before induction of general anesthesia

DRUG

Normal saline

2 ml normal saline as bolus before induction of general anesthesia

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02139241 - The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery | Biotech Hunter | Biotech Hunter